Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multiple sclerosis: Regenerative therapies for MS-hope on the horizon.
Multiple sclerosis in South America: month of birth in different latitudes does not seem to interfere with the prevalence or progression of the disease.
IL-25 prevents T cell-mediated neurotoxicity by decreasing LFA-1 expression.
Factors affecting bone mineral density in multiple sclerosis patients.
Accurate white matter lesion segmentation by k nearest neighbor classification with tissue type priors (kNN-TTPs).
Cognition, cognitive dysfunction, and cognitive rehabilitation in multiple sclerosis.
A possible case of acute disseminated encephalomyelitis after Japanese encephalitis.
[Multiple sclerosis: oral drugs].
Aging with a disability and state vocational rehabilitation services.
Selective upregulation of scavenger receptors in and around demyelinating areas in multiple sclerosis.
Auditory evoked potentials and vestibular evoked myogenic potentials in evaluation of brainstem lesions in multiple sclerosis.
Predictive value of 1 month retinal nerve fiber layer thinning for deficits at 6 months after acute optic neuritis.
Substrate stiffness of endothelial cells directs LFA-1/ICAM-1 interaction: A physical trigger of immune-related diseases?
The Development of Prophylactic and Therapeutic EBV Vaccines.
Epitope mapping of anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a mouse model of multiple sclerosis: microwave-assisted synthesis of the peptide antigens and ELISA screening.
Nudging Oligodendrocyte Intrinsic Signaling to Remyelinate and Repair: Estrogen Receptor Ligand Effects.
Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring.
Coenzyme Q10 supplementation and multiple sclerosis.
Correlations between MRI and Information Processing Speed in MS: A Meta-Analysis.
Validation of the World Health Organization Disability Assessment Schedule II (WHODAS-II) in patients with multiple sclerosis.
How do we manage and treat a patient with multiple sclerosis at risk of tuberculosis?
The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination.
Immune suppression of JC virus gene expression is mediated by SRSF1.
Google Trends: new evidence for seasonality of multiple sclerosis.
Effects of isoxazolo-pyridinone 7e, a potent activator of the nurr1 signaling pathway, on experimental autoimmune encephalomyelitis in mice.

Pages